Brendan A Ford - Net Worth and Insider Trading
Brendan A Ford Net Worth
The estimated net worth of Brendan A Ford is at least $14 Million dollars as of 2025-04-30. Brendan A Ford is the EVP-Corporate Development of Cardinal Health Inc and owns about 103,269 shares of Cardinal Health Inc (CAH) stock worth over $14 Million. Brendan A Ford is also the Director of Navidea Biopharmaceuticals Inc and owns about 11,532 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $2. Details can be seen in Brendan A Ford's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brendan A Ford has not made any transactions after 2015-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Brendan A Ford
Brendan A Ford Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brendan A Ford owns 2 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) , and Cardinal Health Inc (CAH) .
Click here to see the complete history of Brendan A Ford’s form 4 insider trades.
Insider Ownership Summary of Brendan A Ford
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
NAVB | Navidea Biopharmaceuticals Inc | 2015-05-21 | director |
CAH | Cardinal Health Inc | 2006-08-21 | EVP - Corp. Development |
Brendan A Ford Latest Holdings Summary
Brendan A Ford currently owns a total of 2 stocks. Among these stocks, Brendan A Ford owns 103,269 shares of Cardinal Health Inc (CAH) as of August 21, 2006, with a value of $14 Million and a weighting of 100%. Brendan A Ford also owns 11,532 shares of Navidea Biopharmaceuticals Inc (NAVB) as of May 21, 2015, with a value of $2 and a weighting of 0%.
Latest Holdings of Brendan A Ford
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CAH | Cardinal Health Inc | 2006-08-21 | 103,269 | 139.84 | 14,441,137 |
NAVB | Navidea Biopharmaceuticals Inc | 2015-05-21 | 11,532 | 0.00 | 2 |
Holding Weightings of Brendan A Ford
Brendan A Ford Form 4 Trading Tracker
According to the SEC Form 4 filings, Brendan A Ford has made a total of 0 transactions in Cardinal Health Inc (CAH) over the past 5 years. The most-recent trade in Cardinal Health Inc is the sale of 10,350 shares on August 21, 2006, which brought Brendan A Ford around $699,453.
According to the SEC Form 4 filings, Brendan A Ford has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the acquisition of 1,000 shares on May 21, 2015, which cost Brendan A Ford around $26,200.
Insider Trading History of Brendan A Ford
- 1
Brendan A Ford Trading Performance
GuruFocus tracks the stock performance after each of Brendan A Ford's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brendan A Ford is 23.35%. GuruFocus also compares Brendan A Ford's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brendan A Ford within 3 months outperforms 7 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brendan A Ford's insider trading performs compared to the benchmark.
Performance of Brendan A Ford
Brendan A Ford Ownership Network
Ownership Network List of Brendan A Ford
Ownership Network Relation of Brendan A Ford

Brendan A Ford Owned Company Details
What does Navidea Biopharmaceuticals Inc do?
Who are the key executives at Navidea Biopharmaceuticals Inc?
Brendan A Ford is the director of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .
Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Navidea Biopharmaceuticals Inc Insider Transactions
Brendan A Ford Mailing Address
Above is the net worth, insider trading, and ownership report for Brendan A Ford. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Brendan A Ford's mailing address is: Dublin Oh 43235.